XCancer Omaha is a clinical research site located in Omaha, Nebraska, United States 68130.
Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.
XCancer Omaha has participated in 12 clinical trials with 10 currently active.
Therapeutic areas: Advanced Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression, Cancer.
Sponsors: Bayer, Clarity Pharmaceuticals Ltd, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Nebraska · View every site in Omaha
Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
XCancer Omaha has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
XCancer Omaha has 12 clinical trials on record, with 10 currently active. Their work covers Advanced Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression, Cancer.
XCancer Omaha has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.